MDMA’s Breakthrough PTSD Results
53:43–54:22 · 40s
Pollan cites two phase III trials showing about two-thirds of PTSD patients no longer meet the diagnosis after guided MDMA sessions, predicting FDA approval soon.
53:43–54:22 · 40s
Pollan cites two phase III trials showing about two-thirds of PTSD patients no longer meet the diagnosis after guided MDMA sessions, predicting FDA approval soon.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.